Analyst Articles

The adage that there is no such thing as a riskless investment is generally true. There’s a correlation between risk and reward. If you want greater return potential on your investment, you will usually have to take on greater risk. Even Treasury bonds, issued by the U.S. government, carry a… Read More

Sell Jazz Pharmaceuticals (NASDAQ: JAZZ).  As you know, Brain Trust Profits (BRAIN) has merged with Profit Catalyst Alert (PCA), managed by Linda McDonough.  PCA has sold JAZZ today.  The stock price had risen above Brain Trust Profits’ suggested buy-up-to price of $160 and was a… Read More

Buy to open the iShares 20+ Year Treasury Bond ETF (NASDAQ: TLT) September 21, 2018 $118 call option. Pay no more than $2.40. My bond indicator is bullish enough to warrant buying a call on the Treasury Bond ETF. For those following my 3-Pot system, this is a Pot-1 trade. Read More

On Friday morning, we sold four stocks: AAR Corporation (NYSE: AIR), ChannelAdvisor (NYSE: ECOM), AngioDynamics (NASDAQ: ANGO) and Sotheby’s (NYSE: BID). All four stocks have exceeded our suggested buy-up-to price. Amidst the higher market volatility, we decided to take the gains. AAR Corp. has been a consistent performer for us… Read More

Sell AAR Corporation (NYSE: AIR), AngioDynamics (NASDAQ: ANGO). ChannelAdvisor (NYSE: ECOM) and Sotheby’s (NYSE: BID). We recommend taking gains on AIR, ANGO, ECOM, and BID. More details to come in today’s weekly update later. Read More